Pfizer CEO Albert Bourla said Sunday that the company is planning to submit the data it compiled from COVID-19 vaccine trials for children between the ages of 5 and 11 to the Food and Drug Administration quite soon.
"It's a question of days, not weeks," he told ABC News' George Stephanopoulos on Sunday's edition of This Week.
Last week, Pfizer revealed that the vaccine it developed in tandem with BioNTech was safe and effective within the age group even with a smaller dose than the one that's been approved for ages 12 and up.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Once the FDA can review that information, the vaccine will be on track to become available for younger children, which will likely go a long way toward solidifying pandemic-related education policies throughout the U.S.
-
AI workslop is muddying the American workplaceThe explainer Using AI may create more work for others
-
Japan poised to get first woman prime ministerSpeed Read The ruling Liberal Democratic Party elected former Economic Security Minister Sanae Takaichi
-
The 5 best mob movies of all timeThe Week Recommends If you don’t like a good gangster flick, just fuhgeddaboudit
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
Why are autism rates increasing?The Explainer Medical experts condemn Trump administration’s claim that paracetamol during pregnancy is linked to rising rates of neurodevelopmental disorder in US and UK
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Cytomegalovirus can cause permanent birth defectsThe Explainer The virus can show no symptoms in adults
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
